The science of genetics. The business of discovery.Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Draper Associates

First Light Capital

Winklevoss Capital

Jazz Venture Partners

Animal Capital

At One Ventures

Liquid 2 Ventures

Bold Capital Partners

Breyer Capital

Thomas Tull

Animoca Brands

Green Sands Equity

Boost VC

cFund

Paris Hilton

Robert Nelsen

US Innovative Technology Fund

WestRiver Group

Peak 6

In-Q-Tel

Bob Nelsen

Elias Montanari

Sahin Boydas

Victor Vescovo

Colossal Biosciences

IPhone / Mobile Compatible

Google Tag Manager

Google Analytics

Content Delivery Network

WordPress

Global Site Tag

Mobile Non Scaleable Content

Organization Schema

Cloudflare CDN

Person Schema

Chief Operating Officer

Adam Milne

Chief Product Officer

Andrew Busey

Founder and CEO

Ben Lamm

Co-Founder, Chief Legal Officer and Board Member

Brian Beard

VP of Human Resources

Amanda Bastawros

Director, Head of Talent Acquisition

Cheryl Noga

Engineering

Hari Jayamohan

Sr. Director, IT & Security

Jeffery Miles

Jeffery Miles - CSM

Director of Marketing

Jillian McCall

Alexander Titus

Linda Avey

Patrick O'Brien

Founder & CEO

Peter Phillips

Co-Founder & Chief Business Officer

Kent Wakeford

Co-Founder + COO

Sarah Grant

Chief of staff

VP of Strategy

Daniel Breyer

Investor

Emily Castel

Chief Marketing Officer

Executive Advisory Board

Southern US Companies With Fewer Than 1000 Employees (Top 10K)

United States Investors (Top 10K)

Dallas/Fort Worth Metroplex Companies With More Than 10 Employees (Top 10K)

United States Companies With More Than 50 Employees (Top 10K)

Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through innovative science and technology.

Venture Round - Colossal Biosciences

Series B - Colossal Biosciences

Grant - Colossal Biosciences

Series A - Colossal Biosciences

Seed Round - Colossal Biosciences

Dallas

Texas

United States

North America

Colossal Foundation Donates $1.5M USD to the University of Melbourne to Support Avian Conservation

'Lord of the Rings' director invests in Colossal Biosciences

Colossal Biosciences Launches Conservation Foundation With $50M in Funding

Colossal Announces New Indigenous Partnerships and Forms Indigenous Council to Prioritize the Conservation, De-Extinction, Rewilding and Rematriation Issues that Matter to Tribal Communities in the US

De-extinction of the woolly mammoth takes a major step forwards: Scientists reconstruct the chromosomes of a 52,000-year-old creature - and it could allow them to resurrect the lost species

5 Interesting Startup Deals You May Have Missed In April: Firefighting Robots And Animal-Free Eggs

Colossal Announces $7.5M in New Investments in Ancient DNA Academic Research

Colossal Biosciences has made headlines as the de-extinction startup primed to bring back the woolly mammoth. Here’s how the business model actually works.

Woolly mammoth specific gene variants and compositions comprising same

Germany

Europe

Sweden

South Korea

Asia

Hong Kong

Colossal Biosciences owns The Colossal Foundation

Colossal Biosciences owns Colossal Biosciences Boston, Massachusetts

Colossal Biosciences owns Colossal Biosciences Austin, Texas

Trendland is a platform for design, art, fashion, photography, architecture, music, video, and more.

Trendland

Colossal Shop is an online retail platform offering unique and curated products related to art, design, and creativity.

Colossal Shop

Colossal Biosciences is a biotechnology and genetic engineering company focused on de-extinction and conservation biology. It aims to bring back extinct species such as the woolly mammoth, the Tasmanian tiger, and the dodo through genetic engineering and reproductive technology.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 23, 2024 12:37 AM	b09d9e1e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 23, 2024 12:37 AM	cd89c638
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	a567ba54
crunchbase profile	general	Nov 22, 2024 9:31 AM	c016899e
li profile	general	Feb 23, 2024 12:37 AM	032cc845
translate crunchbase fundingrounds	general	Nov 22, 2024 1:53 PM	e671f6d0
peers	general
news basic	general	Feb 23, 2024 12:37 AM	0aabb288
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:COLOSSAL

Colossal Biosciences